Business Wire

PPG

20.5.2022 14:02:12 CEST | Business Wire | Press release

Share
PPG Showcases Innovations in Paints, Coatings, Specialty Materials That Enhance Sustainability, Efficiency, Mobility

PPG (NYSE:PPG) today showcased its latest innovations to media at its production and research and development (R&D) facility in Amsterdam. The event focused on advancements in three key areas – sustainability, efficiency and mobility – reflecting the company’s goals of helping customers lower costs, reduce their environmental footprint and support the global shift to electric vehicles (EVs).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220520005101/en/

Recent PPG innovations highlighted during the event include:

  • PPG CORACHAR® battery fire protection coatings for EVs reduce weight, increase battery performance and support passenger and first-responder safety in case of a fire.
  • PPG ENVIROCRON™ LUM powder coating is the first-ever commercial powder coating that is retroreflective. The coating reflects light back to its source with minimal scattering, making objects like bicycles and road barriers appear brighter at night.
  • The PPG MAVIS™ digital color styling platform assists automotive designers to dramatically accelerate the process of creating new colors and effects for their latest vehicles using exceptionally realistic three-dimensional modeling.
  • PPG SOLARON BLUE PROTECTION™ UV+ blocking technology provides enhanced and durable protection for aircraft windows against ultraviolet exposure and high-energy visible blue light, helping address a key concern for the aviation industry.
  • The PPG SPRAYMASTER™ system is a revolutionary portable sprayer specifically designed for exterior woodwork. It is up to 50% faster than brush/roller application and provides quick drying and excellent opacity in one layer.
  • PPG SIGMAGLIDE™ 1290 silicone-based marine coating prevents fouling species from attaching to a vessel without the use of biocides. Its slippery surface also reduces power demand by up to 20%, helping the shipping industry meet key sustainability goals.
  • The PPG MOONWALK® system is an automated refinish paint mixing system that saves labor time, reduces waste and transforms the refinish mixing room into a clean and safe environment.
  • PPG iSENSE™ exterior can coatings protect cans from damage and provide sensory surface effects, such as a textured feel or visual effects like matte and satin. This allows brands to produce unique designs to improve product differentiation on the shelf.
  • LIGHT & EASY™ exterior masonry coatings by PPG help alleviate the problems faced by painters having to handle heavy cans. It reduces the weight of the paint by up to 30% compared to standard coatings while maintaining the same performance.

“It’s a great privilege to showcase our latest advances,” said Roald Johannsen, PPG vice president, Automotive Coatings, Europe, Middle East and Africa. “Our R&D strength is recognized, with new product sales accounting for 24% of our total sales in 2021. In addition, 38% or our sales were from sustainably advantaged products during the year.”

PPG is focusing on product innovations that link to its 2025 sustainability goals, including increased safety, reduced energy consumption and waste minimization throughout the value chain. To learn more about PPG’s sustainability efforts, visit sustainability.ppg.com .

PPG: WE PROTECT AND BEAUTIFY THE WORLD®
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and specialty materials that our customers have trusted for nearly 140 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 75 countries and reported net sales of $16.8 billion in 2021. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com .

We protect and beautify the world, iSense, MaVis and Solaron Blue Protection are trademarks and CoraChar, Moonwalk and the PPG Logo are registered trademarks of PPG Industries Ohio, Inc.
Sigmaglide is a trademark and PPG SprayMaster is a registered trademark of PPG Coatings Nederland B.V.
Light & Easy is a registered trademark of PPG Architectural Coatings – France.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye